LIVE

JXN

Jackson Financial Inc.

JXN

NYSE·Financial Services·Insurance - Life·Mkt cap $7.3B

$103.86

-0.64%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$82.65 - $123.61

P/E

-17.20

Fwd P/E

4.57

Beta

1.33

Div Yield

3.25%

Avg Vol

605.5K

Shares Out

70.4M

Mkt Cap

$7.3B

Price action

Price chart

Up 18.6% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Diversified annuity product portfolio addressing multiple retirement income and savings needs
  • Extensive multi-channel distribution network including independent broker-dealers, banks, and registered investment advisors
  • Established market presence with 15+ years of operational history and brand recognition
  • Integrated investment management services enhancing customer value proposition
  • Scale in institutional products providing stable funding and diversified revenue streams

Bear Case

1 risk

  • Average volatility.

Growth

Turning profitable

Rising demand for annuities driven by aging Baby Boomer population seeking guaranteed retirement income

Value

Deep value opportunity - significant discount to Life Insurance peers

Momentum

Stable

+0.8% over 3m

Quality

Excellent

Strong fundamentals

Dividend

Solid

3.25% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 5, 2026

Q2 26 RECAP

MAY 5, 2026

Reported EPS of $5.94 vs $5.96 consensus (-0.3% surprise). Revenue of $2.9B vs $1.9B expected (+49.8%).

EPS miss
Rev beat +49.8%

EPS surprise · last 4Q

0 of 1 beats

Q2 26

-0.3%

Next: Aug 5, 2026

Revenue trend · last 8Q

-85%

-141%

-36%

+1474%

-22%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$1.2B

$2.1B

$133.0M

$3.7B

-$483.0M

$1.3B

$2.1B

$2.9B

Margins · last 8Q

Gross

Operating

Profit

-14.6%

Wall Street consensus

2 analysts · 50% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

50%

Hold

1

50%

Sell

0%

Median Price Target

Latest: Keefe, Bruyette & Woods · May 13, 2026

vs Industry

How JXN stacks vs Insurance - Life

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.